Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
10x Genomics Inc (GB:0A88)
LSE:0A88
10x Genomics (0A88) Share Price & Analysis
3 Followers
0A88 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$15.34 - $63.24
Previous Close$20.44
Volume2.43K
Average Volume (3M)1.83K
Market Cap
$2.38B
Enterprise Value$2.10B
Total Cash (Recent Filing)$371.81M
Total Debt (Recent Filing)$92.18M
Price to Earnings (P/E)―
Beta2.31
Next Earnings
Aug 08, 2024EPS Estimate
-$0.48Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume67
30 Day Avg. Volume1,835
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.37
Enterprise Value/Gross Profit5.14
Enterprise Value/Ebitda-10.00
Forecast
1Y Price Target
$27.55Price Target Upside34.77% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
10x Genomics News
Bulls Say, Bears Say
Bulls Say
Customer BaseA large customer base of core labs limits dependency on NIH funding.
Market PositionTXG is positioned to capture significant excitement generated by spatial research.
Technology And InnovationTXG has superior technology versus competitors, validated by Genentech publication.
Bears Say
Adoption BarriersChromium's high cost is cited as the greatest barrier to adoption or to increasing the number of samples.
Competitive PressureIncreasing competition is eroding the inelastic demand that 10x Genomics' market-leading single cell platform once enjoyed.
Growth ConcernsChromium growth will remain under pressure, with greater volume declines and/or pricing pressure than current management expectations.
---
Options Prices
Currently, No data available
---
Ownership Overview
17.85% Insiders
34.01% Mutual Funds
39.39% Other Institutional Investors
8.75% Public Companies and
Individual Investors
0A88 FAQ
What was 10x Genomics Inc’s price range in the past 12 months?
10x Genomics Inc lowest share price was $15.34 and its highest was $63.23 in the past 12 months.
What is 10x Genomics Inc’s market cap?
Currently, no data Available
When is 10x Genomics Inc’s upcoming earnings report date?
10x Genomics Inc’s upcoming earnings report date is Aug 08, 2024 which is in 12 days.
How were 10x Genomics Inc’s earnings last quarter?
10x Genomics Inc released its earnings results on Apr 30, 2024. The company reported -$0.5 earnings per share for the quarter, the consensus estimate of -$0.5 by $0.
Is 10x Genomics Inc overvalued?
According to Wall Street analysts 10x Genomics Inc’s price is currently Undervalued.
Does 10x Genomics Inc pay dividends?
10x Genomics Inc does not currently pay dividends.
What is 10x Genomics Inc’s EPS estimate?
10x Genomics Inc’s EPS estimate is -$0.48.
How many shares outstanding does 10x Genomics Inc have?
10x Genomics Inc has 105,651,596 shares outstanding.
What happened to 10x Genomics Inc’s price movement after its last earnings report?
10x Genomics Inc reported an EPS of -$0.5 in its last earnings report, expectations of -$0.5. Following the earnings report the stock price went down -8.148%.
Which hedge fund is a major shareholder of 10x Genomics Inc?
Among the largest hedge funds holding 10x Genomics Inc’s share is ARK Investment Management LLC. It holds 10x Genomics Inc’s shares valued at 236M.
---
10x Genomics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$27.55 (34.77% Upside)
$27.55 (34.77% Upside)
Blogger Sentiment
Bullish
GB:0A88 Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Sold Shares
Worth $217.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.26%
12-Months-Change
Fundamentals
Return on Equity
-34.75%
Trailing 12-Months
Asset Growth
-8.99%
Trailing 12-Months
Company Description
10x Genomics Inc
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson, Kevin D. Ness and Eduard Diviu Terradas on July 2, 2012 and is headquartered in Pleasanton, CA.
---
0A88 Earnings Call
Q1 2024
0:00 / 0:00
---
0A88 Revenue Breakdown
77.51% Consumables
19.96% Instruments
2.54% Services
---
0A88 Stock 12 Month Forecast
Average Price Target
$27.55
▲(34.77% Upside)
Technical Analysis
Best Analysts Covering 0A88
1 Year
1 Year Success Rate
6/12 ratings generated profit
1 Year Average Return
-9.57%
reiterated a buy rating 3 months ago
Copying Tejas Savant's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -9.57% per trade.
---